These younger kids could be vaccinated by Halloween, Pfizer CEO says.
Related Articles
-
The CDC has identified 19 monkeypox cases in the U.S. Here’s what we know so far.
The Centers for Disease Control and Prevention had confirmed 19 cases of monkeypox across 10 U.S. states as of...
-
ERs prepare for omicron surge after holidays
Hospitals across the country are bracing for a post-holiday surge in Covid-19 cases, driven by the extremely contagious omicron...
-
J&J vaccine remains on pause as CDC panel requests more information
An advisory panel to the Centers for Disease Control and Prevention declined to make any new recommendations on the...
-
After FDA approval of Pfizer vaccine, several steps still left before kids under 12 can be vaccinated
The Food and Drug Administration’s decision to grant full approval to Pfizer-BioNTech’s two-dose Covid-19 vaccine Monday for people ages...
-
Warmer winters mean more tick bites and Lyme disease risk year-round
While most bugs die in the winter, ticks are relatively impervious to the freezing temperatures — and as the...
-
Will there be a new Covid vaccine in the fall?
Although Covid cases remain low in the U.S., vaccine experts are already looking toward the winter, with eyes on...
-
Pickleball-related injuries are on the rise. Here’s who is most at risk.
As pickleball’s popularity has skyrocketed, so have the number of serious injuries among players. Bone fractures related to pickleball...
-
Experimental Alzheimer’s drug slowed cognitive decline for people in early stages of the disease
Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
Recent Comments